Research and Professional Experience: 1987 – 1992 Research Fellow, Department of Internal Medicine and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA 1992 – 1993 Research Associate, Department of Immunology, The Scripps Research Institute, La Jolla, California, USA 1993 – 1996 Assistant Member (Assistant Professor), Department of Immunology, The Scripps Research Institute, La Jolla, California, USA 1996 – 2004 Associate Professor, Department of Immunology, The Scripps Research Institute, La Jolla, California, USA 2004 – 2007 Professor, Department of Immunology, The Scripps Research Institute, La Jolla, California, USA 2007 – Present Adjunct Professor (Professor of Immunology), Department of Immunology, The Scripps Research Institute, La Jolla, California, USA 2007 – Present Professor, School of Life Sciences, Xiamen University, China Awards: Jean Stas Award (Belgium), 1991 Established Investigatorship Award (American Heart Association), 1995 Distinguished Young Scholar (B class, National Science Foundation of China), 2001 Chang Jiang Scholar (The Ministry of Education, China), 2002 Lu Jiaxi Excellent Mentor (Lu Jiaxi Science and Education Foundation), 2009 YaoMingKangDe Life Science and Chemistry Award (1st Prize, Wuxi Pharma), 2009 Chang Jiang Scholar Achievement Award (The Ministry of Education of China), 2009 First Prize in Natural Science Research (The Ministry of Education of China), 2011 Voted one of the ten most innovative scientists in China (Chinese Science Net), 2011 Overseas Chinese Contribution Award (All-China Fed. Returned Overseas Chinese), 2012 Nationwide Outstanding Doctoral Dissertation, Mentor Award (The Ministry of Education of China), 2012 The sixth Tan Jiazhen Life Science Achievement Award (Tan Jiazhen Award Foundation), 2013 The Second Prize of National Natural Science Award (The State Council, China), 2013 Outstanding scientific and technological expert in Fujian (Fujian province government, China), 2014 Outstanding scientific and technological expert in China (China Association for Science and Technology), 2014 Sanofi- Cell Research Outstanding Paper Prize, 2014 Professional Society Members for: American Society for Molecular Biology and Biochemistry The American Association of Immunologists American Society for Microbiology International Society of Endotoxin International Communication Committee of Chinese Society for Genetics Protein Committee of Chinese Society for Biochemistry and Molecular Biology (Vice Chairperson) Chinese Society for Cell Biology (Vice President) Patents: 1. Patent Number: 5,837,810 Date of Issue: 1998.11.17 Name of Patent: Polypeptides of lipopolysaccharide binding protein 2. Patent Number: 6,010,856 Date of Issue: 2000.01.04 Name of Patent: Assay systems and methods for measuring p38 MAP kinase, and modulators thereof 3. Patent Number: WO 2008/057171 A2 Date of Issue: 2007.10.16 Name of Patent: 4-1BB ligand in inflammatory diseases. Polypeptides of lipopolysaccharide binding protein 4. Patent Number: ZL 200810071442.X Date of Issue: 2008.12.10 Name of Patent: 聚苯乙烯-聚(苯乙烯-交替甘露糖基马来酸)及其制备方法与应用 5. Patent Number: ZL 200810071898.6 Date of Issue: 2009.02.11 Name of Patent: 聚(苯乙烯-交替-马来酸钠)的用途 6. Patent Number: ZL 2007 1 0009304.4 Date of Issue: 2012.02.01 Name of Patent:高唾液酸含量的免疫球蛋白抗体的制备方法与应用 Study in Han’s laboratory: Dr. Jiahuai Han is known for the discovery of the p38 signaling pathway, one of the most important pathways in intracellular signaling transduction. This pathway plays important roles in many biological processes including cell cycle regulation, cell proliferation, cell differentiation and senescence, as well as immune reactions, development and tumorigenesis. Another current focus of Han`s lab is molecular mechanisms of RIP3 dependent necrosis, which is based on a recent finding in this laboratory revealing that RIP3 is a major player in controlling programmed necrosis. The research in Han’s Lab will lead to a better understanding of the molecular mechanisms of inflammation, cardiovascular disease and tumorigenesis, and thus provides new ideas for the development of therapeutic intervention for these diseases. |